Improved platelet counts during prolonged tranexamic therapy for Quebec platelet disorder implicate the underlying fibrinolytic defect as the cause of lower platelet counts
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 2020
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- Antifibrinolytic Agents (MeSH)
- Blood Coagulation Disorders (MeSH)
- Blood Platelets (MeSH)
- Factor V Deficiency (MeSH)
- Fibrinolysin (MeSH)
- Fibrinolysis (MeSH)
- Hemarthrosis (MeSH)
- Hematoma (MeSH)
- Hemorrhage (MeSH)
- Humans (MeSH)
- Immunology (Science Metrix)
- Male (MeSH)
- Membrane Proteins (MeSH)
- Middle Aged (MeSH)
- Platelet Count (MeSH)
- Postoperative Hemorrhage (MeSH)
- Prospective Studies (MeSH)
- Tranexamic Acid (MeSH)
- Wound Healing (MeSH)